Dr. Lawrence May Joins Targeted Medical Pharma as Medical Director

Targeted Medical Pharma Inc.

Los Angeles, CA, April 23, 2019 — Targeted Medical Pharma Inc. (OTC:TRGM), an international biotechnology company and innovator in the development and distribution of scientifically based medical foods and dietary supplements announced the appointment of Lawrence May, M.D., F.A.C.P., as Medical Director.

“Dr. May brings extensive clinical, scientific and business experience developed over a thirty five year career in private practice and leadership roles in both public and private companies.” said Marcus Charuvastra, Managing Director of Targeted Medical Pharma. “Dr. May has played an integral role in the development and research of many of our medical food and dietary supplement products. He has extensive clinical experience educating and validating the clinical benefits of medical nutrition with his patients.”

Dr. May earned his M.D. from Harvard Medical School (’74) and has practiced primary care internal medicine integrating nutrition and lifestyle into the care of patients. Dr. May previously served as Chairman of the Medical Advisory Board and Executive Vice President for Medical and Scientific affairs at Herbalife International. Dr. May has appeared as an expert on numerous television and radio shows. He has consulted for law firms, pharmaceutical and biotech companies. He has worked for government agencies and nonprofits, including the Cancer Prevention Society, Los Angeles Free Clinic and the California Board of Medical Quality Assurance (BMQA). Dr. May has formulated outstanding dietary supplements offered in physician offices and successful infomercials. For over thirty years he has been on the full time clinical faculty of UCLA Geffen School of Medicine.

Dr. May earned his undergraduate degree Magna Cum Laude in Economics from Harvard College (’70) where he was elected to Phi Beta Kappa.  

“I am excited to rejoin Targeted Medical Pharma to advance the company’s mission to integrate efficacious supplements into patient care,” said Dr. May. “I am committed to educating healthcare providers and patients about safer, effective approaches for pain, anxiety, sleep and mood disorders. Collaborating with clinicians, scientists and regulators, Targeted Medical Pharma will improve the quality of life of an expanding population, particularly senior citizens, the most vulnerable to the side effects of pharmaceuticals.”

Connect with us on Twitter and Facebook.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a Los Angeles-based international biotechnology company that develops medical foods for the dietary management of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. 

Forward Looking Statement

This press release may contain forward-looking statements related to Targeted Medical Pharma’s business strategy, outlook, objectives, plans, intentions or goals. Targeted Medical Pharma expressly disclaims any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.